首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   40618篇
  免费   2070篇
  国内免费   143篇
耳鼻咽喉   473篇
儿科学   1009篇
妇产科学   1028篇
基础医学   6985篇
口腔科学   1221篇
临床医学   3561篇
内科学   6590篇
皮肤病学   1052篇
神经病学   3525篇
特种医学   2462篇
外科学   5149篇
综合类   292篇
一般理论   10篇
预防医学   3418篇
眼科学   609篇
药学   3437篇
中国医学   241篇
肿瘤学   1769篇
  2023年   286篇
  2022年   358篇
  2021年   793篇
  2020年   512篇
  2019年   823篇
  2018年   1302篇
  2017年   926篇
  2016年   1098篇
  2015年   1219篇
  2014年   1484篇
  2013年   2211篇
  2012年   3210篇
  2011年   3571篇
  2010年   1825篇
  2009年   1153篇
  2008年   2320篇
  2007年   2484篇
  2006年   2385篇
  2005年   2092篇
  2004年   1979篇
  2003年   1918篇
  2002年   1643篇
  2001年   722篇
  2000年   888篇
  1999年   604篇
  1998年   289篇
  1997年   253篇
  1996年   213篇
  1995年   184篇
  1994年   130篇
  1993年   103篇
  1992年   180篇
  1991年   196篇
  1990年   225篇
  1989年   182篇
  1988年   181篇
  1987年   141篇
  1986年   162篇
  1985年   165篇
  1984年   158篇
  1983年   141篇
  1982年   127篇
  1981年   128篇
  1980年   111篇
  1979年   121篇
  1978年   116篇
  1977年   96篇
  1976年   98篇
  1975年   119篇
  1974年   87篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Post-induction hypotension is common and associated with postoperative complications. We hypothesised that pneumatic leg compression reduces post-induction hypotension in elderly patients undergoing robot-assisted laparoscopic prostatectomy. In this double-blind randomised study, patients were allocated randomly to the pneumatic leg compression group (n = 50) or control (n = 50). In the intervention group, pneumatic leg compression was initiated before induction of anaesthesia. In the control group, pneumatic leg compression was initiated 20 min after anaesthesia induction. The primary outcome was the incidence of post-induction hypotension in these groups. Post-induction hypotension was defined as systolic blood pressure < 90 mmHg during the first 20 min after induction. Haemodynamic variables and area under the curve of post-induction systolic blood pressure over time were assessed. Complications associated with pneumatic leg compression were recorded, including: peripheral neuropathy; compartment syndrome; extensive bullae beneath the leg sleeves; and pulmonary thromboembolism. The incidence of post-induction hypotension decreased in the pneumatic leg compression group compared with that in the control group; 5 (10%) vs. 29 (58%), respectively, p < 0.001. In the pneumatic leg compression group, the lowest systolic, diastolic and mean blood pressures 20 min after induction of anaesthesia were significantly greater than the control group. Pneumatic leg compression resulted in an increased area under the curve of systolic blood pressure in the first 20 min after induction, p = 0.001. There were no pneumatic leg compression-related complications. Pneumatic leg compression reduced post-induction hypotension in elderly patients undergoing robot-assisted laparoscopic prostatectomy, suggesting that it is an effective and safe intervention to prevent post-induction hypotension among elderly patients undergoing general anaesthesia.  相似文献   
3.
4.
5.
6.
7.
Clinical Oral Investigations - The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of...  相似文献   
8.
9.
10.

Introduction

In the phase II/III KEYNOTE-010 study (ClinicalTrials.gov, NCT01905657), pembrolizumab significantly prolonged overall survival over docetaxel in patients with previously treated, programmed death ligand 1–expressing (tumor proportion score ≥ 1%), advanced NSCLC. Health-related quality of life (HRQoL) results are reported here.

Methods

Patients were randomized 1:1:1 to pembrolizumab 2 or 10 mg/kg every 3 weeks or docetaxel 75 mg/m2 every 3 weeks. HRQoL was assessed using European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLC) Core 30 (C30), EORTC QLQ–Lung Cancer 13 (LC13), and EuroQoL-5D. Key analyses included mean baseline-to-week-12 change in global health status (GHS)/quality of life (QoL) score, functioning and symptom domains, and time to deterioration in a QLQ-LC13 composite endpoint of cough, dyspnea, and chest pain.

Results

Patient reported outcomes compliance was high across all three instruments. Pembrolizumab was associated with better QLQ-C30 GHS/QoL scores from baseline to 12 weeks than docetaxel, regardless of pembrolizumab dose or tumor proportion score status (not significant). Compared with docetaxel, fewer pembrolizumab-treated patients had “deteriorated” status and more had “improved” status in GHS/QoL. Nominally significant improvement was reported in many EORTC symptom domains with pembrolizumab, and nominally significant worsening was reported with docetaxel. Significant prolongation in true time to deterioration for the QLQ-LC13 composite endpoint emerged for pembrolizumab 10 mg/kg compared to docetaxel (nominal two-sided p = 0.03), but not for the 2-mg/kg dose.

Conclusions

These findings suggest that HRQoL and symptoms are maintained or improved to a greater degree with pembrolizumab than with docetaxel in this NSCLC patient population.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号